Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motohiro Tamiya

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Advances in Therapy|July 12, 2024
A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese PatientsMotohiro Tamiya, Shunichiro Iwasawa, Yusuke Sasaki, et al.
JTO Clinical and Research Reports|January 9, 2023
Rapid Response to Sotorasib of a Patient With <i>KRAS</i> G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case ReportKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 17, 2008
[An autopsy case of sarcomatoid malignant mesothelioma mimicking adenocarcinoma with sarcomatoid elements of lung]Motohiro Tamiya, Hiroyuki Yamane, Haruko Terada, et al.
Thoracic Cancer|April 4, 2017
Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatmentToru Kumagai, Madoka Kimura, Takako Inoue, et al.
Respiratory Medicine Case Reports|February 3, 2017
Afatinib-induced severe esophagitis in a lung cancer patient with an activated epidermal growth factor receptor mutation: A case reportTakako Inoue, Madoka Kimura, Motohiro Tamiya, et al.
Thoracic Cancer|March 2, 2024
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case reportTakako Inoue, Kei Kunimasa, Motohiro Tamiya, et al.
Pathology International|March 14, 2019
Pulmonary carcinosarcoma characterized by small round cells with neuroendocrine, myogenic, and chondrogenic differentiation: An extremely rare caseHarumi Nakamura, Motohiro Tamiya, Yukinaga Sato, et al.
Investigational New Drugs|January 13, 2022
Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort studyHayato Kawachi, Motohiro Tamiya, Kinnosuke Matsumoto, et al.
Thoracic Cancer|October 25, 2021
Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edemaKei Kunimasa, Takahisa Kawamura, Motohiro Tamiya, et al.
JTO Clinical and Research Reports|August 15, 2022
Immunochemotherapy Disrupts Peripherally Located Lung Squamous Cell Carcinoma Resulting in Pleuritis: A Report of Two Cases, Case ReportKei Kunimasa, Tomohiro Maniwa, Motohiro Tamiya, et al.
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Advances in Therapy|July 12, 2024
A DPC Database Study on the Safety of Atezolizumab/Carboplatin/Etoposide in Extensive-Disease Small Cell Lung Cancer in Japanese PatientsMotohiro Tamiya, Shunichiro Iwasawa, Yusuke Sasaki, et al.
JTO Clinical and Research Reports|January 9, 2023
Rapid Response to Sotorasib of a Patient With <i>KRAS</i> G12C-Mutated Lung Cancer With Cancer-Associated Disseminated Intravascular Coagulation: A Case ReportKei Kunimasa, Motohiro Tamiya, Takako Inoue, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|December 17, 2008
[An autopsy case of sarcomatoid malignant mesothelioma mimicking adenocarcinoma with sarcomatoid elements of lung]Motohiro Tamiya, Hiroyuki Yamane, Haruko Terada, et al.
Thoracic Cancer|April 4, 2017
Delayed pseudoprogression of lung adenocarcinoma accompanied with interstitial lung disease during chemotherapy after nivolumab treatmentToru Kumagai, Madoka Kimura, Takako Inoue, et al.
Respiratory Medicine Case Reports|February 3, 2017
Afatinib-induced severe esophagitis in a lung cancer patient with an activated epidermal growth factor receptor mutation: A case reportTakako Inoue, Madoka Kimura, Motohiro Tamiya, et al.
Thoracic Cancer|March 2, 2024
Exceptionally long-lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD-L1: A case reportTakako Inoue, Kei Kunimasa, Motohiro Tamiya, et al.
Pathology International|March 14, 2019
Pulmonary carcinosarcoma characterized by small round cells with neuroendocrine, myogenic, and chondrogenic differentiation: An extremely rare caseHarumi Nakamura, Motohiro Tamiya, Yukinaga Sato, et al.
Investigational New Drugs|January 13, 2022
Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort studyHayato Kawachi, Motohiro Tamiya, Kinnosuke Matsumoto, et al.
Thoracic Cancer|October 25, 2021
Capmatinib successfully overcomes tepotinib-induced intolerable peripheral edemaKei Kunimasa, Takahisa Kawamura, Motohiro Tamiya, et al.
JTO Clinical and Research Reports|August 15, 2022
Immunochemotherapy Disrupts Peripherally Located Lung Squamous Cell Carcinoma Resulting in Pleuritis: A Report of Two Cases, Case ReportKei Kunimasa, Tomohiro Maniwa, Motohiro Tamiya, et al.
Pageof 20